Beckley Waves
Seed Round in 2023
Beckley Waves is a venture studio focused on building and investing in the psychedelic ecosystem. The company is dedicated to funding, supporting, and mentoring emerging entrepreneurs and leaders who are working to establish the operational infrastructure necessary for a global psychedelic marketplace. By facilitating connections between entrepreneurs and essential resources such as investors, advisors, and strategic partners, Beckley Waves aims to empower these innovators to thrive and achieve success in their endeavors. Through its initiatives, the company plays a crucial role in advancing the development of the psychedelic industry.
Wisdo Health
Series A in 2023
Wisdo Health is an AI-powered social health platform focused on enhancing mental and physical well-being by fostering meaningful connections among users. The company offers an evidence-based peer support and benefits navigation platform that addresses the detrimental effects of social isolation and loneliness. By connecting individuals with shared experiences, Wisdo Health aims to improve health outcomes and reduce medical costs. The platform empowers users to learn from one another, facilitating personal growth and resilience in the face of life’s challenges and opportunities.
Homecoming
Seed Round in 2022
Homecoming is a provider of patient engagement tools specifically designed for psychedelic therapy. The company has developed a digital companion application that supports patients throughout their therapeutic process. This application promotes accountability and fosters long-term change by offering personalized guides, tasks, and daily check-ins. Additionally, it provides preparation and integration support within a single, user-friendly platform that includes relevant patient program content. This enables healthcare professionals to effectively guide their patients on their healing journeys, enhancing the therapeutic experience and outcomes.
Wavepaths
Seed Round in 2021
Wavepaths, established in 2018 and based in London, specializes in developing accessible technology for psychedelic therapy. The company creates personalized soundtracks using intelligent technologies and immersive media, aiming to facilitate inner exploration and emotional reconnection during drug-free therapeutic sessions. Their offerings span the fields of information technology, healthcare, and personal health.
The Shift Network
Series A in 2021
The Shift Network, Inc. is dedicated to fostering a global movement aimed at catalyzing an evolutionary shift in consciousness to create a more enlightened society based on sustainability, peace, health, and prosperity. Founded in 2010, the company offers virtual educational services, including online summits and courses that focus on spirituality, health, wellness, personal growth, and relationships. Through these programs, The Shift Network has reached over 200,000 participants worldwide, empowering individuals to transform their lives and contribute to a more harmonious world.
TRU LUV
Funding Round in 2020
TRU LUV, established in 2015 and headquartered in Toronto, Canada, specializes in designing and developing self-care application software. Its core product offers a range of digital tools, including backgrounds, paper kits, and coloring pages, aimed at promoting relaxation and stress reduction. The company's unique approach, reflected in its BENEFICENCE model and TERRA software architecture, combines elements of economics, organizational management, software development, human-computer interaction, and personal development. TRU LUV's mission is to create engaging, fun, and nourishing experiences that help users lead stress-free lives, positioning itself as a pioneering force in the intersection of technology and personal well-being.
Pear Therapeutics
Series C in 2019
Pear Therapeutics, Inc. is a Boston-based commercial-stage healthcare company specializing in software-based digital therapeutics, also known as Prescription Digital Therapeutics (PDTs). Founded in 2013, the company develops clinically validated software solutions designed to treat a range of behavioral health disorders, including addiction, anxiety, depression, and chronic insomnia. Its suite of products includes mobile digital therapies that reward patients for engagement, and specific tools like reSET and reSET-O, aimed at treating substance use disorders. The company also offers Somryst, which provides neurobehavioral interventions for insomnia, and operates PearConnect, a patient services center that connects patients with advocates and resources, ensuring support throughout their treatment journey. Pear Therapeutics aims to enhance treatment outcomes by integrating digital therapies with pharmaceuticals and providing comprehensive support for patients, clinicians, and payors.
Pear Therapeutics
Series B in 2018
Pear Therapeutics, Inc. is a Boston-based commercial-stage healthcare company specializing in software-based digital therapeutics, also known as Prescription Digital Therapeutics (PDTs). Founded in 2013, the company develops clinically validated software solutions designed to treat a range of behavioral health disorders, including addiction, anxiety, depression, and chronic insomnia. Its suite of products includes mobile digital therapies that reward patients for engagement, and specific tools like reSET and reSET-O, aimed at treating substance use disorders. The company also offers Somryst, which provides neurobehavioral interventions for insomnia, and operates PearConnect, a patient services center that connects patients with advocates and resources, ensuring support throughout their treatment journey. Pear Therapeutics aims to enhance treatment outcomes by integrating digital therapies with pharmaceuticals and providing comprehensive support for patients, clinicians, and payors.
Muse, developed by InteraXon, is a neurotechnology company that produces a headband designed to provide real-time feedback on brain activity during meditation. Founded in 2007 and headquartered in Toronto, Ontario, the company specializes in brain-computer interfaces, utilizing research-grade ambulatory electroencephalograms and EEG sensors. Muse’s technology captures brainwaves and translates them into digital signals, which are then processed to deliver insights on mental activity, heart rate, breathing, and body movements. This data enables users to enhance their meditation practices and mindfulness, fostering a deeper connection with their mental and physical states. Through its innovative hardware and software platform, Muse aims to support users in achieving greater mental clarity and well-being.
MeetMindful
Seed Round in 2017
MeetMindful, Inc. is an online dating platform established in 2013 and headquartered in Denver, Colorado. The company caters to individuals who prioritize health, well-being, and mindfulness in their lives. It provides a space for like-minded singles to connect and fosters a community that values personal growth and intentional living. In addition to facilitating connections, MeetMindful offers access to relationship advice from experts, enhancing the dating experience for its users. The platform encourages members to embrace the challenges and vulnerabilities that accompany personal development, promoting a deeper and more meaningful connection among its users.
eMindful, Inc. is a company based in Orlando, Florida, specializing in online and mobile interactive courses focused on improving mental and physical well-being. Founded in 2003 and previously known as McCabe Consulting Associates Inc., eMindful offers evidence-based mindfulness programs that address various health issues, including stress, obesity, chronic pain, and addiction. Its eMindful Life platform allows members to connect and practice mindfulness skills daily. The company serves a diverse clientele, including individuals, corporations, universities, and government institutions, aiming to enhance health outcomes and promote a high-performing workforce. Additionally, eMindful collaborates with Fortune 500 employers and leading health plans to help manage healthcare costs and improve overall quality of care.
Pear Therapeutics
Series A in 2016
Pear Therapeutics, Inc. is a Boston-based commercial-stage healthcare company specializing in software-based digital therapeutics, also known as Prescription Digital Therapeutics (PDTs). Founded in 2013, the company develops clinically validated software solutions designed to treat a range of behavioral health disorders, including addiction, anxiety, depression, and chronic insomnia. Its suite of products includes mobile digital therapies that reward patients for engagement, and specific tools like reSET and reSET-O, aimed at treating substance use disorders. The company also offers Somryst, which provides neurobehavioral interventions for insomnia, and operates PearConnect, a patient services center that connects patients with advocates and resources, ensuring support throughout their treatment journey. Pear Therapeutics aims to enhance treatment outcomes by integrating digital therapies with pharmaceuticals and providing comprehensive support for patients, clinicians, and payors.
Twill
Convertible Note in 2015
Twill is a developer of a software-enabled healthcare platform focused on enhancing mental and physical wellness. The company offers a web and mobile-based technology that evaluates users' happiness through both subjective and objective assessments. In addition, Twill provides a variety of programs and games designed to promote healthier mindsets. This approach enables individuals, employers, and care delivery systems to effectively address issues such as stress, depression, anxiety, and social isolation, which are often associated with chronic illness. By integrating these tools, Twill aims to support users in achieving improved overall well-being.
Muse, developed by InteraXon, is a neurotechnology company that produces a headband designed to provide real-time feedback on brain activity during meditation. Founded in 2007 and headquartered in Toronto, Ontario, the company specializes in brain-computer interfaces, utilizing research-grade ambulatory electroencephalograms and EEG sensors. Muse’s technology captures brainwaves and translates them into digital signals, which are then processed to deliver insights on mental activity, heart rate, breathing, and body movements. This data enables users to enhance their meditation practices and mindfulness, fostering a deeper connection with their mental and physical states. Through its innovative hardware and software platform, Muse aims to support users in achieving greater mental clarity and well-being.